FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010644808> ?p ?o ?g. }

• W2010644808 endingPage "441" @default.
• W2010644808 startingPage "432" @default.
• W2010644808 abstract "ERG, an ETS family transcription factor, is known to be expressed in endothelial cells, and oncogenic ERG gene fusions occur in subsets of prostatic carcinoma, acute myeloid leukemia, and Ewing sarcoma. In this study, we immunohistochemically investigated nuclear ERG expression using a new monoclonal antibody, CPDR ERG-MAb, that is highly specific for detecting ERG protein and ERG-expressing prostate carcinomas. A broad range of vascular endothelial (n=250), other mesenchymal (n=973), and epithelial tumors (n=657) was examined to determine the use of ERG immunohistochemistry in surgical pathology. Only immunostains with ERG-positive normal endothelia (internal control) were considered valid, and only nuclear staining was considered to be positive. In adult tissues, ERG was restricted to endothelial cells and to a subset of bone marrow precursors, but early fetal mesenchyme and subpopulations of fetal cartilage were also positive. In vascular tumors, ERG was expressed in endothelia of all hemangiomas and lymphangiomas, and typically extensively expressed in 96 of 100 angiosarcomas, 42 of 43 epithelioid hemangioendotheliomas, and all 26 Kaposi sarcomas. Among nonvascular mesenchymal tumors, only blastic extramedullary myeloid tumors (7 of 10) and rare Ewing sarcomas (2 of 29) were positive. Among epithelial tumors, 30 of 66 prostatic adenocarcinomas showed focal-to-extensive ERG positivity, with no immunoreactivity in the normal prostate. Other carcinomas and epithelial tumors (n=643) were ERG negative, with the exception of 1 of 42 large cell undifferentiated pulmonary carcinomas and 1 of 27 mesotheliomas, each of which showed focal nuclear ERG positivity. On the basis of the above observations, ERG is a highly specific new marker for benign and malignant vascular tumors. Among epithelial tumors, ERG shows a great promise as a marker to identify prostatic carcinoma in both primary and metastatic settings." @default.
• W2010644808 created "2016-06-24" @default.
• W2010644808 creator A5003457663 @default.
• W2010644808 creator A5004993292 @default.
• W2010644808 creator A5007664700 @default.
• W2010644808 creator A5023145654 @default.
• W2010644808 creator A5024934444 @default.
• W2010644808 creator A5045582598 @default.
• W2010644808 creator A5091150805 @default.
• W2010644808 date "2011-03-01" @default.
• W2010644808 modified "2023-10-18" @default.
• W2010644808 title "ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma" @default.
• W2010644808 cites W1519030262 @default.
• W2010644808 cites W1843078452 @default.
• W2010644808 cites W1935960420 @default.
• W2010644808 cites W1979807471 @default.
• W2010644808 cites W2007702573 @default.
• W2010644808 cites W2007784442 @default.
• W2010644808 cites W2015437876 @default.
• W2010644808 cites W2016941384 @default.
• W2010644808 cites W2027845674 @default.
• W2010644808 cites W2028123362 @default.
• W2010644808 cites W2036004730 @default.
• W2010644808 cites W2045191477 @default.
• W2010644808 cites W2045832625 @default.
• W2010644808 cites W2049072650 @default.
• W2010644808 cites W2050982044 @default.
• W2010644808 cites W2070830966 @default.
• W2010644808 cites W2074855390 @default.
• W2010644808 cites W2075559846 @default.
• W2010644808 cites W2092159426 @default.
• W2010644808 cites W2094532843 @default.
• W2010644808 cites W2099436620 @default.
• W2010644808 cites W2099576121 @default.
• W2010644808 cites W2115242278 @default.
• W2010644808 cites W2129752592 @default.
• W2010644808 cites W2168977372 @default.
• W2010644808 cites W2317993485 @default.
• W2010644808 cites W2318053510 @default.
• W2010644808 cites W2326950559 @default.
• W2010644808 cites W2337737811 @default.
• W2010644808 cites W87202805 @default.
• W2010644808 doi "https://doi.org/10.1097/pas.0b013e318206b67b" @default.
• W2010644808 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6880747" @default.
• W2010644808 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21317715" @default.
• W2010644808 hasPublicationYear "2011" @default.
• W2010644808 type Work @default.
• W2010644808 sameAs 2010644808 @default.
• W2010644808 citedByCount "307" @default.
• W2010644808 countsByYear W20106448082012 @default.
• W2010644808 countsByYear W20106448082013 @default.
• W2010644808 countsByYear W20106448082014 @default.
• W2010644808 countsByYear W20106448082015 @default.
• W2010644808 countsByYear W20106448082016 @default.
• W2010644808 countsByYear W20106448082017 @default.
• W2010644808 countsByYear W20106448082018 @default.
• W2010644808 countsByYear W20106448082019 @default.
• W2010644808 countsByYear W20106448082020 @default.
• W2010644808 countsByYear W20106448082021 @default.
• W2010644808 countsByYear W20106448082022 @default.
• W2010644808 countsByYear W20106448082023 @default.
• W2010644808 crossrefType "journal-article" @default.
• W2010644808 hasAuthorship W2010644808A5003457663 @default.
• W2010644808 hasAuthorship W2010644808A5004993292 @default.
• W2010644808 hasAuthorship W2010644808A5007664700 @default.
• W2010644808 hasAuthorship W2010644808A5023145654 @default.
• W2010644808 hasAuthorship W2010644808A5024934444 @default.
• W2010644808 hasAuthorship W2010644808A5045582598 @default.
• W2010644808 hasAuthorship W2010644808A5091150805 @default.
• W2010644808 hasBestOaLocation W20106448082 @default.
• W2010644808 hasConcept C103796816 @default.
• W2010644808 hasConcept C121608353 @default.
• W2010644808 hasConcept C126322002 @default.
• W2010644808 hasConcept C142724271 @default.
• W2010644808 hasConcept C198826908 @default.
• W2010644808 hasConcept C204232928 @default.
• W2010644808 hasConcept C2776235491 @default.
• W2010644808 hasConcept C2776340970 @default.
• W2010644808 hasConcept C2777546739 @default.
• W2010644808 hasConcept C2780827179 @default.
• W2010644808 hasConcept C4224716 @default.
• W2010644808 hasConcept C55493867 @default.
• W2010644808 hasConcept C71924100 @default.
• W2010644808 hasConcept C86803240 @default.
• W2010644808 hasConceptScore W2010644808C103796816 @default.
• W2010644808 hasConceptScore W2010644808C121608353 @default.
• W2010644808 hasConceptScore W2010644808C126322002 @default.
• W2010644808 hasConceptScore W2010644808C142724271 @default.
• W2010644808 hasConceptScore W2010644808C198826908 @default.
• W2010644808 hasConceptScore W2010644808C204232928 @default.
• W2010644808 hasConceptScore W2010644808C2776235491 @default.
• W2010644808 hasConceptScore W2010644808C2776340970 @default.
• W2010644808 hasConceptScore W2010644808C2777546739 @default.
• W2010644808 hasConceptScore W2010644808C2780827179 @default.
• W2010644808 hasConceptScore W2010644808C4224716 @default.
• W2010644808 hasConceptScore W2010644808C55493867 @default.
• W2010644808 hasConceptScore W2010644808C71924100 @default.
• W2010644808 hasConceptScore W2010644808C86803240 @default.

• next